Published Articles
CDSCO Approves First Indigenous mRNA Vaccine Platform for Tropical Diseases
India's drug regulator grants breakthrough approval for a domestically developed mRNA vaccine platform targeting dengue and chikungunya.
Should India Reclassify Paracetamol? The Hepatotoxicity Debate
As paracetamol-related liver injuries rise in India, experts debate whether the world's most popular analgesic needs stricter regulatory controls.
Biosimilars in India: Regulatory Landscape and Market Opportunities
An analysis of India's evolving biosimilar regulations, market dynamics, and the country's position as a global biosimilar hub.
Understanding Antibiotic Resistance: What Every Patient Should Know
A patient-friendly guide to antibiotic resistance — why it happens, how to prevent it, and what India is doing to combat this growing threat.
Metformin vs Glipizide: A Comprehensive Comparison for Type 2 Diabetes
An evidence-based comparison of two first-line oral hypoglycemic agents, examining efficacy, safety profiles, and patient outcomes in the Indian population.
The Pharmacokinetics of Semaglutide: Why Once-Weekly Dosing Works
A deep dive into the molecular modifications that give semaglutide its remarkably long half-life, enabling convenient once-weekly dosing for diabetes and obesity.